Outcome Measures: |
Primary: Percent Change in Serum LDL-cholesterol Levels From Week 16 to Week 20 (LOCF) (ITT2), Percent Change from Week 16 to Week 20 (LOCF), week20 minus week16 | Secondary: Percent Change in Serum LDL-cholesterol Levels From Baseline to Week 16 (LOCF) (ITT1), Percent Change from Baseline to Week 16 (LOCF), week16 minus week0|Change in Phosphorus(P), Calcium(Ca), Calcium-phosphorus Ion Product(PxCa) and Parathyroid Hormone (PTH), 16 weeks and 20 weeks|Vital Signs, Adverse Events, and Laboratory Values, throughout study
|
Locations: |
Brest, Belarus|Gomel, Belarus|Grodno, Belarus|Minsk, Belarus|Vitebsk, Belarus|Gabrovo, Bulgaria|Plovdiv, Bulgaria|Sofia, Bulgaria|Karlovac, Croatia|Osijek, Croatia|Esbjerg, Denmark|Roskilde, Denmark|Jakarta, Indonesia|Malang, Indonesia|Medan, Indonesia|Palembang, Indonesia|Tamanlarea Makassar, Indonesia|Ashkelon, Israel|Nahariya, Israel|Bellano, Italy|Catania, Italy|Lecco, Italy|Merate, Italy|Milano, Italy|Oggiono, Italy|Riga, Latvia|Valmiera, Latvia|Kaunas, Lithuania|Kedauniai, Lithuania|Vilnius, Lithuania|Johor, Malaysia|Kelantan, Malaysia|Penang, Malaysia|Perak, Malaysia|Bucharest, Romania|Timisoara, Romania|Singapore, Singapore|Bangkok, Thailand|Phitsanulok, Thailand
|